Prof. Masataka Kikuyama
Prof. Masataka Kikuyama
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan
Title: Early diagnosis to improve the poor prognosis of pancreatic cancer
Pancreatic cancer (PC) has a poor prognosis, because the diagnosis of PC is delayed. Early diagnosis is needed to improve prognosis. For early diagnosis of PC, patients with clinical manifestations suggestive of PC and high risk for developing PC need to be selected for examinations for PC. Signs suggestive of PC should not be missed, and the details of risks for PC should be understood. Multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) could be performed for diagnosing PC, while the diagnostic ability of these examinations for PC is limited. Endoscopic diagnostic procedures such as endoscopic ultrasonography including fine-needle aspiration and endoscopic retrograde pancreatocholangiography including serial pancreatic-juice aspiration cytologic examination (SPACE) could be recommended for a detailed examination to diagnose earlier pancreatic carcinoma.
Dr. Masataka Kikuyama is a Director of Gastroenterology in Tokyo Metropolitan Cancer and Infectious Disease Komagome Hospital. He received his M.D. degree in 1985 and Ph.D. degree in 1996 from Hamamatsu University School of Medicine. Dr. Kikuyama focuses on early diagnosis of pancreatic cancer and endoscopic procedures in pancreatobiliary diseases, especially in post-surgery state. Dr. Kikuyama and his co-workers have studied the strategy for diagnosing pancreatic cancer at the early stage and reported the usefulness of endoscopic ultrasonography and repeated pancreatic juice cytology using nasopancreatic tube (Serial Pancreatic-juice Aspiration Cytologic Examination, SPACE) for that, moreover have studied endoscopic methods to treat pancreatic-biliary disorders in post surgery state and reported ERCP-related and EUS-guided treatments for those disorders.